#BioInnovations
🚀 175+ inscrits. Des rencontres. Des découvertes. Et surtout… une énergie incroyable!
👉 Hier, le Centre d’Innovations adMare BioInnovations a ouvert ses portes au cœur du Technoparc Montréal... et quelle matinée!!
+infos et photos: www.linkedin.com/feed/update/...
October 7, 2026 at 2:19 PM
🚀 175+ registered attendees. Connections. Discoveries. And above all… incredible energy!
👉 Yesterday, the adMare BioInnovations Innovation Centre opened its doors in the heart of Technoparc Montréal… and what a morning!!
+info and pix: lnkd.in/p/dKTFENvi
October 7, 2026 at 2:35 PM
👉 2 days to go!
🚀 On Tuesday, October 6, the adMare BioInnovations Innovation Centre opens its doors for a special event. From 10 a.m. to noon, come experience firsthand a place where science, innovation, entrepreneurship and talent!
+info: www.linkedin.com/feed/update/...
October 4, 2026 at 1:12 PM
👉 Portes ouvertes au Centre d’Innovations adMare!
🙂 Le 6 octobre, de 10 h à 12 h, le Centre d’Innovations adMare BioInnovations de Montréal ouvre ses portes à l’ensemble de l’écosystème des sciences de la vie.
+ infos: lnkd.in/p/gjvmFD74
September 22, 2026 at 3:15 PM
👉 Open House at the adMare Innovation Centre!
🙂 On October 6, from 10 a.m. to 12 p.m., the adMare BioInnovations Innovation Centre in Montréal is opening its doors to the entire life sciences ecosystem.
+info: lnkd.in/p/gDK2hJ-u
September 22, 2026 at 3:29 PM
🧪 YUL Labs offers laboratory spaces ranging from 250 to 5,000 sq. ft., located at two strategic locations:
▶ Technoparc Montréal
▶ Centre d’Innovations adMare BioInnovations
+infos: www.linkedin.com/feed/update/...
#YULLabs #LifeSciences #Laboratories
September 15, 2026 at 12:16 PM
🧪 YUL Labs propose des espaces de laboratoire de 250 à 5 000 pi², situés dans deux emplacements stratégiques :
▶ Technoparc Montréal
▶ Centre d’Innovations adMare BioInnovations
+infos: lnkd.in/p/g9kWwUui
#YULLabs #LifeSciences #Laboratories #LabSpace #Biotechnology
September 15, 2026 at 12:07 PM
🚀 Two Shows. Two communities. One shared energy. This week, Biotech Connect was back on the road with two events: CQIB and adMare BioInnovations.
See pix and info here: linkedin.com/feed/update/...
September 11, 2026 at 4:10 PM
🚀 Deux Salons. Deux communautés. Une même énergie. Cette semaine, Biotech Connect était de retour sur le terrain avec deux rendez-vous: CQIB et adMare BioInnovations.
+ de photos et infos ici:
www.linkedin.com/feed/update/...
September 11, 2026 at 4:12 PM
Eclipsebio Launches eSTRAND RNA QC™ to Enhance RNA Characterization for Therapeutics#United_States#San_Diego#Eclipsebio#RNA_QC#eSTRAND_RNA_QC
Eclipsebio Launches eSTRAND RNA QC™ to Enhance RNA Characterization for Therapeutics
Eclipse Bioinnovations presents eSTRAND RNA QC™, a groundbreaking assay that utilizes nanopore sequencing to improve RNA characterization for therapeutic development.
third-news.com
September 1, 2026 at 1:05 PM
🇮🇳インドのArboreal Bioinnovationsが、酵母タンパク質や次世代甘味料の事業拡大に向け約38.4億円を調達

異なるカテゴリーにまたがる5種類の原料を展開し、1,100社を超える顧客の製品に採用されているとのこと🥄

新たに調達した資金で、さらなる展開拡大を進めます。

インドは機能性食品の購入率が世界で3番目に高く、購入経験のある国民が90%近くに上るとの調査結果も。

高まる消費者需要を反映して、昨年末から同種の大型調達💰が相次いでいます。
framtiden.earth/2026/08/11/a...
インドのArboreal Bioinnovationsが、酵母タンパク質や次世代甘味料の事業拡大に向け約38.4億円を調達 – Framtiden
インドのフードテック企業Arboreal Bioinnovationsが、酵母や植物由来のタンパク質、代替砂糖、食物繊維といった機能性原料の生産規模を拡大するため、シリーズAラウンドで23億ルピー(約38億4,000万円)の調達を行いました。
framtiden.earth
August 11, 2026 at 3:44 AM
Arboreal Bioinnovations has raised ₹230 crore ($24M) in a Series A round led by EAAA Alternatives and Omnivore.

The startup develops specialty food and nutraceutical ingredients and will use the funding to expand manufacturing and R&D.

#FoodTech #StartupFunding #Nutraceuticals #Startups
August 3, 2026 at 4:59 AM
India's Arboreal Bags $24M to Scale Yeast Proteins, Next-Gen Sweeteners & More
Indian food tech startup Arboreal Bioinnovations has secured ₹23 crore ($24.2M) in Series A funding to scale up functional ingredients like yeast and plant proteins, sugar replacers, and fibres. To bring its functional ingredient solutions to an Indian market increasingly hungry for them, Lucknow-based Arboreal Bioinnovations has closed a major funding round. The startup has raised ₹23 crore ($24.2M) in Series A financing led by EAAA Alternatives and Omnivore, with further participation from existing shareholder Rainmatter by Zerodha. Arboreal makes a range of ingredients targeted towards the evolving nutritional, sensory and commercial needs of Indian consumers, spanning proteins from yeast and plants, a suite of sweeteners, cocoa, fibres, and marine collagen. Through its Bioprot label, the company supplies yeast protein to popular Indian brands SuperYou, Cosmix and Yoga Bar. It will use the funds to expand its manufacturing capacity, boost its R&D activities, and accelerate the commercialisation of its next-generation ingredient portfolio. “The shift towards clean-label and functional foods requires engineered ingredients that deliver clear health benefits without sacrificing taste or margins. Arboreal fills a critical market gap with locally developed formulations,” said Jinesh Shah, managing partner of Omnivore. “From sweetener alternatives to novel yeast proteins and collagens, Arboreal’s R&D...
www.greenqueen.com.hk
August 3, 2026 at 8:29 AM
BC's life sciences sector is growing. adMare’s new M4 Innovation Centre expands wet lab capacity, helping companies move from discovery to commercialization faster. Learn more: https://ow.ly/iMfn50ZiTru
Article 6 – adMare BioInnovations’ New Co-location Facility - Trade and Invest BC
New wet lab space accelerates B.C. life sciences growth.
ow.ly
July 7, 2026 at 4:01 PM
BC's life sciences sector is growing. adMare’s new M4 Innovation Centre expands wet lab capacity, helping companies move from discovery to commercialization faster. Learn more: https://ow.ly/iMfn50ZiTru
Article 6 – adMare BioInnovations’ New Co-location Facility - Trade and Invest BC
New wet lab space accelerates B.C. life sciences growth.
ow.ly
June 30, 2026 at 10:00 PM
With funding for biotech declining post-pandemic, Geoffrey Meyerson's Banyan BioInnovations is restructuring capital and clinical processes to navigate late-stage development challenges. Their aim is to enhance drug approval success rates. www.institutionalinvestor.com/article/why-...
Why Biotech Struggles to Finish What It Starts
Biotech doesn’t typically fail in the lab. It fails later — after early promise and before approval — when the cost of proving a drug works comes up against a funding system built for an earlier stage...
www.institutionalinvestor.com
May 7, 2026 at 8:00 PM
Our panel discussion features Scott McAuley of Paradigm Capital, Gordon McCauley of adMare Bioinnovations, OCI's Jeff van Heumen, Paul McCracken of CPP Investments moderated by Sigrun Watson of ThinkrBelle Inc.

The topic: How can life sciences companies access capital to grow and compete?
May 27, 2025 at 3:04 PM
May 9, 2026 at 10:00 PM
Banyan BioInnovations launches with over $100M dedicated to creating NewCos from clinical assets. In addition, they form a strategic partnership with Icon, a leading CRO in the industry.
May 9, 2026 at 10:00 PM
Check out this job: Tenure-Track Faculty Position at Pharmaceutical Sciences, The College of Pharmacy, in collaboration with BioInnovations in Brain Cancer Initiative (BIBC) program
November 30, 2024 at 10:50 AM